Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT) — Aldo Maggioni (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
Shared by
Aldo Maggioni
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
Article
2005
en
Authors
+7 more
Aldo Maggioni
RL
Roberto Latini
PC
Peter E. Carson
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)
Aldo Maggioni
,
Roberto Latini
,
Peter E. Carson
Article
2003
Valsartan reduces the incidence of atrial fibrillation in the patients with heart failure in the Val-HeFT Trial
Aldo Maggioni
Article
2004
Effect of Valsartan Added to Background ACE Inhibitor Therapy in Patients with Heart Failure: Results from Val-HeFT
Henry Krum
,
Peter E. Carson
,
Csaba Farsang
,
Aldo Maggioni
,
Robert Glazer
,
Nora Aknay
,
YannTong Chiang
,
Jay N. Cohn
Article
2003
Prognostic Value of Aldosterone in Heart Failure – Results from Val-HeFT
Inder S. Anand
,
Roberto Latini
,
Robert Glazer
,
Allen Hester
,
Serge Masson
,
Aldo Maggioni
,
Nora Aknay
,
Jay N. Cohn
Article
2010
Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)
Serge Masson
,
Scott D. Solomon
,
Laura Angelici
,
Roberto Latini
,
Inder S. Anand
,
Margaret F. Prescott
,
Aldo Maggioni
,
Gianni Tognoni
,
Jay N. Cohn
Discussion(0)
No comments yet. Be the first to comment.